Literature DB >> 2390424

Pharmacokinetics of propofol when given by intravenous infusion.

D J Morgan1, G A Campbell, D P Crankshaw.   

Abstract

We have previously shown with i.v. bolus studies that the elimination of propofol is much slower than previously reported. Now we have studied the implications of this for prolonged i.v. infusion of propofol in seven patients who received continuous infusions of propofol for up to 9 h. Values of elimination half-life ranged from 13.1 to 44.7 h, systemic clearance from 1.02 to 1.63 l h-1 and volume of distribution from 1390 to 3940 l and these were similar to those obtained with bolus administration. The large volume of distribution is consistent with the high octanol/blood partition coefficient, which was found to be 72.0. Despite the very long elimination half-life, blood propofol concentrations appeared to approach steady state within 20 min rather than the 4-5 half-lives normally expected. This is because for this drug, which displays multicompartment pharmacokinetics, the rate of initial rise of blood concentrations is governed primarily by the very short distribution half-life of the drug. Therefore, the long elimination half-life of propofol is probably of little significance in designing infusions regimens, but the lower systemic clearance should be taken into account to avoid unwanted accumulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390424      PMCID: PMC1368287          DOI: 10.1111/j.1365-2125.1990.tb03755.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Disturbances in hepatic blood flow during anesthesia and surgery.

Authors:  S I Gelman
Journal:  Arch Surg       Date:  1976-08

2.  Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection.

Authors:  G F Plummer
Journal:  J Chromatogr       Date:  1987-10-09

3.  Extended blood collection period required to define distribution and elimination kinetics of propofol.

Authors:  G A Campbell; D J Morgan; K Kumar; D P Crankshaw
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

4.  Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia.

Authors:  A Shafer; V A Doze; S L Shafer; P F White
Journal:  Anesthesiology       Date:  1988-09       Impact factor: 7.892

5.  Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol.

Authors:  P J Simons; I D Cockshott; E J Douglas; E A Gordon; K Hopkins; M Rowland
Journal:  Xenobiotica       Date:  1988-04       Impact factor: 1.908

6.  Pharmacokinetics and protein binding of propofol in patients with cirrhosis.

Authors:  F Servin; J M Desmonts; J P Haberer; I D Cockshott; G F Plummer; R Farinotti
Journal:  Anesthesiology       Date:  1988-12       Impact factor: 7.892

7.  Pharmacokinetic and pharmacodynamic modelling of propofol ('Diprivan') in volunteers and surgical patients.

Authors:  J Schüttler; H Stoeckel; H Schwilden
Journal:  Postgrad Med J       Date:  1985       Impact factor: 2.401

8.  Disposition of propofol administered as constant rate intravenous infusions in humans.

Authors:  E Gepts; F Camu; I D Cockshott; E J Douglas
Journal:  Anesth Analg       Date:  1987-12       Impact factor: 5.108

9.  Pharmacokinetics of propofol in female patients. Studies using single bolus injections.

Authors:  I D Cockshott; L P Briggs; E J Douglas; M White
Journal:  Br J Anaesth       Date:  1987-09       Impact factor: 9.166

10.  Disposition of propofol in patients undergoing surgery. A comparison in men and women.

Authors:  N H Kay; J W Sear; J Uppington; I D Cockshott; E J Douglas
Journal:  Br J Anaesth       Date:  1986-10       Impact factor: 9.166

  10 in total
  14 in total

1.  A bodyweight-dependent allometric exponent for scaling clearance across the human life-span.

Authors:  Chenguang Wang; Mariska Y M Peeters; Karel Allegaert; Heleen J Blussé van Oud-Alblas; Elke H J Krekels; Dick Tibboel; Meindert Danhof; Catherijne A J Knibbe
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

Review 2.  Pharmacologic Considerations for Pediatric Sedation and Anesthesia Outside the Operating Room: A Review for Anesthesia and Non-Anesthesia Providers.

Authors:  Narjeet Khurmi; Perene Patel; Molly Kraus; Terrence Trentman
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

Review 3.  Immunosuppressive aspects of analgesics and sedatives used in mechanically ventilated patients: an underappreciated risk factor for the development of ventilator-associated pneumonia in critically ill patients.

Authors:  Michael A Smith; Maho Hibino; Bonnie A Falcione; Katherine M Eichinger; Ravi Patel; Kerry M Empey
Journal:  Ann Pharmacother       Date:  2013-11-04       Impact factor: 3.154

4.  Propofol modulates agonist-induced transient receptor potential vanilloid subtype-1 receptor desensitization via a protein kinase Cepsilon-dependent pathway in mouse dorsal root ganglion sensory neurons.

Authors:  Peter J Wickley; Ryo Yuge; Mary S Russell; Hongyu Zhang; Michael A Sulak; Derek S Damron
Journal:  Anesthesiology       Date:  2010-10       Impact factor: 7.892

5.  Free and bound propofol concentrations in human cerebrospinal fluid.

Authors:  Andrzej L Dawidowicz; Rafal Kalitynski; Anna Fijalkowska
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

Review 6.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

Review 7.  Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation.

Authors:  B Fulton; E M Sorkin
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

8.  [Drugs for intravenous induction of anesthesia: propofol].

Authors:  D Bolkenius; C Dumps; E Halbeck
Journal:  Anaesthesist       Date:  2018-02       Impact factor: 1.041

9.  The use of PBPK modeling across the pediatric age range using propofol as a case.

Authors:  Robin Michelet; Jan Van Bocxlaer; Karel Allegaert; An Vermeulen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-10-08       Impact factor: 2.745

10.  The Effects of Propofol and Sevoflurane on Postoperative Delirium in Older Patients: A Randomized Clinical Trial Study.

Authors:  Xinchun Mei; Hai-Lin Zheng; Cheng Li; Xin Ma; Hui Zheng; Edward Marcantonio; Zhongcong Xie; Yuan Shen
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.